Grandfield & Dodd’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.51K Hold
10,000
– – ﹤0.01% 216
2026
Q2
$8.81K Hold
10,000
– – ﹤0.01% 217
2026
Q1
$6.05K Hold
10,000
– – ﹤0.01% 209
2025
Q4
$7.7K Hold
10,000
– – ﹤0.01% 207
2025
Q3
$10.1K Hold
10,000
– – ﹤0.01% 211
2025
Q2
$13.3K Buy
+10,000
New +$13.6K ﹤0.01% 212

Other funds holding PDSB

Grandfield & Dodd's PDSB Position: Q3 2026 in Review

Grandfield & Dodd held its PDS Biotechnology (PDSB) position steady in Q3 2026 at 10,000 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #216.

Grandfield & Dodd first reported a position in PDSB in Q2 2025 and has held it in 6 quarters since. The position peaked at $13.3K in Q2 2025. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Grandfield & Dodd held 10,000 shares of PDS Biotechnology worth $7.51K as of Q3 2026.
  • Grandfield & Dodd left its PDS Biotechnology share count unchanged in Q3 2026.
  • PDS Biotechnology made up ﹤0.01% of Grandfield & Dodd's portfolio in Q3 2026, its #216 holding.
  • Grandfield & Dodd first reported a position in PDS Biotechnology in Q2 2025 and has held it in 6 quarters since.
  • Grandfield & Dodd's PDS Biotechnology position peaked at $13.3K in Q2 2025.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Grandfield & Dodd's 13F filing for Q3 2026, filed 29 Oct 2026.